Our data suggest the possibility that Angptl1 might enhance and reduce osteoblastic bone formation and osteoclastic bone resorption in mice, respectively, which might leading to an increase in bone mass and a target of bone metabolic disorders, such as osteoporosis. Here, ANGPTL1 is linked to metabolic bone disorder.